Navigation Links
Aethlon Medical Announces the Appointment of Laszlo Radvanyi, Ph.D. to its Scientific Advisory Board
Date:1/17/2013

>About The Aethlon Hemopurifier® 

The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of infectious viral pathogens and immunosuppressive proteins from the entire circulatory system.  In the treatment of Hepatitis C virus (HCV), human studies have demonstrated that Hemopurifier® therapy may improve immediate, rapid and sustained virologic response rates when administered in the first few days of standard-of-care drug therapy.   In addition to accelerating viral load depletion, post-treatment analysis of the Hemopurifier® has documented the capture of up to 300 billion HCV copies of HCV during a single six-hour treatment.  Access to Hemopurifier® therapy is available on a compassionate-use basis through the Medanta Medicity Institute (Medicity), a leading center for medical tourism in India.  The Medicity is offering treatment access to infected individuals who previously failed or subsequently relapsed standard-of-care drug regimens.  The Hemopurifier® is also being offered as a salvage therapy to infected individuals who suffer a viral breakthrough during standard-of-care therapy. U.S. studies of the Hemopurifier® are currently pending approval of an IDE submitted to FDA.  

The Aethlon Hemopurifier® and Cancer

In addition to the opportunity to address a broad-spectrum of infectious viral pathogens, the Hemopurifier® has been discovered to capture tumor-derived exosomes underlying several forms of cancer.  Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. Beyond possessing immunosuppressive properties, tumor-derived exosomes facilitate tumor growth, metastasis, and the de
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical (AEMD) Note: A Medical Device Strategy to Address Metastatic Melanoma
2. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
3. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
4. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
5. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
6. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
7. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
8. Aethlon Medical Announces Notice of Allowance of U.S. Patent Application Covering a Medical Device to Remove Microvesicular Particles, Including Exosomes
9. Aethlon Medical (AEMD) Note: Cancer Research Discovery - Melanoma Exosomes Fuel Organ Metastasis
10. Aethlon Medical to Present at Todays Security Research Associates 8th Annual Growth Conference
11. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015  The report on breast cancer therapeutics: ... cancer drugs on the basis of the molecules which ... the inner lining of milk ducts or lobules responsible ... of tumor that can spread to other cells present ... in lobules is referred as lobular carcinoma, while the ...
(Date:9/2/2015)... LONDON , Sept. 2, 2015 ... Forecasts Summary Advanced dressings have steadily ... treatment of a variety of wound indications, such ... fluid management, infection control, and physical protection become ... a greater role in standard therapy. This ...
(Date:9/2/2015)... MONROVIA, Calif. , Sept. 2, 2015 STAAR ... and marketer of implantable lenses and delivery systems for the ... William P. Wall to the Company,s Board. ... Abrams Capital, a Boston -based investment firm, ... member of the Board of Directors, and chair of the ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2William P. Wall Appointed to STAAR Surgical Board of Directors 2
... CEL-SCI Corporation,(Amex: CVM ) announced today that it ... its lead drug Multikine(R) on October 8, 2008.,This dedicated ... for,CEL-SCI,s pivotal Phase III clinical trial for first-line therapy ... for,sale following approval of the drug. The facility, which ...
... 0901 is Being Developed as an Oral Dosage Form ... at Improving Glycemic Control in Adults With Type 2 ... (OTCBB: ORMP.OB), a developer of oral drug delivery,systems, announced ... a GLP1-analog., ORMD 0901 belongs to the Incretin ...
Cached Medicine Technology:CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008 2CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008 3Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform 2
(Date:9/2/2015)... CT (PRWEB) , ... September 02, 2015 , ... ... $1 million gift from the Abraham and Mildred Goldstein Charitable Trust to establish ... timing of the gift comes six months after WCHN recruited nationally known gynecologic ...
(Date:9/2/2015)... ... September 02, 2015 , ... Date and time: Oct. 3, 2015, 9 ... School, 600 Tomlinson Road, Bryn Athyn, Pa 19009 , Cost: $50 per person; includes ... New York Times best-selling author Sam Keen based on his new book which he ...
(Date:9/2/2015)... ... September 02, 2015 , ... ERT, a ... cloud analytics and workflow solutions today announced the September 2015 installments to ... participate in interactive programs in which ERT scientists and partner subject matter ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... Affairs Officer following the departure of Kristen Dietz, former Chief Operations Officer. ... released the following statement welcoming Mr. Salot: “ Stanley H. Salot Jr , ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... a large stream of mixed documents that include EOBs, payments, and payment related ... extracting the data needed to reconcile their billing, with one efficient process and ...
Breaking Medicine News(10 mins):Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3Health News:Healtec® Announces Executive Leadership Change 2Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2
... defenses, making antibiotics more effective , , WEDNESDAY, March ... engineered a virus that disables the defense systems ... , The scientists said this approach could ... and kill bacteria that have already become antibiotic ...
... progressive degeneration of retinal ganglion cells and their axons ... to identify a way to stop or prevent the ... together a panel of 39 scientists to discuss the ... from the Fourth Annual ARVO/Pfizer Ophthalmics Research Institute Conference ...
... Wash., March 4 Verathon(R) is pleased to ... instrument, with AortaScan(TM) Mode to help physicians identify ... This new addition to the BladderScan(R) BVI 9000 ... PriMed MidWest 2009 conference in Rosemont, IL on ...
... 4 The National Council on Disability (NCD) today ... health care provided to service members and veterans with ... (TBI).According to NCD Chairperson John R. Vaughn, "The wars ... are currently disabling for many, and potentially disabling for ...
... OAKLAND, Calif., March 4 Chronic kidney disease increases ... (AF), the most common type of heart arrhythmia, according ... the current online issue of Circulation. It has ... risk factor for cardiovascular disease. This study is the ...
... Any diet will do? Not if you want to lose fat ... levels so you,ll be less likely to develop diabetes and heart ... to cheat on your diet. And not if you want to ... have a better chance of achieving all these goals if you ...
Cached Medicine News:Health News:Engineered Viruses Could Battle Superbugs 2Health News:Experts examine causes, treatment and prevention of glaucoma 2Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 2Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 3Health News:Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms 4Health News:National Council on Disability Says More Needs to be Done for Service Members and Veterans With Post Traumatic Stress Disorder and Traumatic Brain Injury 2Health News:National Council on Disability Says More Needs to be Done for Service Members and Veterans With Post Traumatic Stress Disorder and Traumatic Brain Injury 3Health News:Kidney Disease Increases the Risk of Stroke in Patients With the Most Common Type of Heart Arrhythmia, According to Kaiser Permanente Study 2Health News:Kidney Disease Increases the Risk of Stroke in Patients With the Most Common Type of Heart Arrhythmia, According to Kaiser Permanente Study 3Health News:Kidney Disease Increases the Risk of Stroke in Patients With the Most Common Type of Heart Arrhythmia, According to Kaiser Permanente Study 4Health News:Is one diet as good as another? U of I study says no and tells you why 2Health News:Is one diet as good as another? U of I study says no and tells you why 3
... 525 is an assayed quality control ... of blood gas, electrolyte, metabolite, and ... this control makes it the ideal ... It is available in three (3) ...
Xsera Rapid HIV-1/2 Antibody Controls are unassayed positive and negative quality control materials used for monitoring the performance of qualitative rapid HIV-1 and HIV-2 test kits....
For the qualitative detection of igG antibodies specific to Helicobacter pylori in human serum, plasma and whole blood specimens...
For the qualitative detection of human occult blood in fecal specimens....
Medicine Products: